NBCNews.comEarly Results Show High Response Rate Achieved With BCMA CAR T-cell Therapy in Multiple MyelomaTargeted OncologyTreatment with chimeric antigen receptor (CAR) T cells that target B-cell maturation protein (BMCA) achieved clinical remissions … Continue reading
WBRC FOX6 News – WBRC.com |
Gene-based therapy may thwart a tough blood cancer
WBRC FOX6 News – WBRC.com (HealthDay News) — Genetically tuning a person’s own immune cells to target cancer appears to provide long-lasting protection against a blood cancer called multiple myeloma, an early trial from China shows. The treatment, called CAR T-cell therapy … Blood cancer treatment called ‘revolutionary’ after all study patients respondedkgw.com |
|
CAR–T Trials Boast Promising Results
The Scientist Multiple myeloma cellsWIKIMEDIA, KGHNanjing Legend Biotech’s chimeric antigen receptor T–cell (CAR-T) therapy induced some level of remission within two months in 33 of 35 multiple myeloma patients in an ongoing clinical trial, according to results … |
|
Voyager Selects Gene Therapy Candidate for Huntington’s Clinical Trials
Huntington’s Disease News Voyager Therapeutics has a new candidate for the treatment of Huntington’s disease. The selected gene therapy is called VY-HTT01 and aims to prevent the production of protein from the mutant huntingtin gene (HTT). The compound is now undergoing … |
|
CAR–T Cells Produce 100% ORR in Advanced Multiple Myeloma
Clinical Oncology News Chicago—In an early clinical experience, a novel autologous chimeric antigen receptor T (CAR–T) cell therapy resulted in a remarkable 100% objective response rate (ORR) in multiple myeloma. In patients with a follow-up of at least four months, all … |
Healthline |
Using Stem Cells to Heal Broken Bones
Healthline “We are just at the beginning of a revolution in orthopedics,” Dan Gazit, co-director of the Skeletal Regeneration and Stem Cell Therapy Program in the Department of Surgery and the Cedars-Sinai Board of Governors Regenerative Medicine Institute, said … |
|
UIC Launches Center for Stem Cell and Regenerative Medicine
Newswise (press release) Newswise — The University of Illinois at Chicago College of Medicine will launch a new center that will focus on understanding tissue regeneration and pioneering future developments in stem cell biology as a means to repair diseased organs and tissues. |